Primary treatment of breast cancer by modified radical mastectomy, radiotherapy, and chemotherapy.
作者信息
Moore F D
出版信息
Ann R Coll Surg Engl. 1980 Jan;62(1):45-9.
Abstract
摘要
相似文献
1
Primary treatment of breast cancer by modified radical mastectomy, radiotherapy, and chemotherapy.
Ann R Coll Surg Engl. 1980 Jan;62(1):45-9.
2
[Occult breast cancer: 9 cases report and review].
Zhonghua Wai Ke Za Zhi. 1994 Nov;32(11):668-9.
3
[Clinical analysis of resectable breast cancer: a report of 6 263 cases].
Ai Zheng. 2005 Mar;24(3):327-31.
4
[Neoadjuvant chemotherapy in the treatment of breast cancer. Results and prospectives].
Minerva Ginecol. 1997 Sep;49(9):393-7.
5
6
[Breast carcinoma in the elderly].
Ann Ital Chir. 2002 Sep-Oct;73(5):505-8; discussion 508-9.
7
[Problems of organ-preserving treatment of breast cancer (lecture)].
Khirurgiia (Mosk). 1997(4):8-14.
8
[Locoregional treatment of breast cancer: surgery and radiotherapy].
Rev Prat. 1998 Jan 1;48(1):53-9.
9
[Effective treatment strategy in elderly breast cancer patients].
Orv Hetil. 2005 Jan 2;146(1):15-21.
10
[Radiotherapy and delayed breast reconstruction with implant: examination of compatibility].
Magy Onkol. 2002;46(4):323-6. Epub 2003 Feb 1.
本文引用的文献
1
2
Hormone receptors: their role in predicting prognosis and response to endocrine therapy.
Semin Oncol. 1978 Dec;5(4):428-33.
3
Estrogen receptors and responses to chemotherapy and hormonal therapy in advanced breast cancer.
N Engl J Med. 1978 Dec 14;299(24):1330-4. doi: 10.1056/NEJM197812142992403.
4
The relation between estrogen receptors and response rate to cytotoxic chemotherapy in metastatic breast cancer.
N Engl J Med. 1978 Jun 1;298(22):1223-8. doi: 10.1056/NEJM197806012982203.
5
Antihormone treatment of stage IV breast cancer.
Cancer. 1979 Feb;43(2):444-50. doi: 10.1002/1097-0142(197902)43:2<444::aid-cncr2820430207>3.0.co;2-c.
6
Current status of estrogen and progesterone receptors in breast cancer.
Cancer. 1977 Jun;39(6 Suppl):2934-47. doi: 10.1002/1097-0142(197706)39:6<2934::aid-cncr2820390680>3.0.co;2-p.
7
The CMF program for operable breast cancer with positive axillary nodes. Updated analysis on the disease-free interval, site of relapse and drug tolerance.
Cancer. 1977 Jun;39(6 Suppl):2904-15. doi: 10.1002/1097-0142(197706)39:6<2904::aid-cncr2820390677>3.0.co;2-8.
8
Kinetic, hormonal and clinical studies with aminoglutethimide in breast cancer.
Cancer. 1977 Jun;39(6 Suppl):2948-58. doi: 10.1002/1097-0142(197706)39:6<2948::aid-cncr2820390681>3.0.co;2-9.
9
L-phenylalanine mustard (L-PAM) in the management of primary breast cancer. An update of earlier findings and a comparison with those utilizing L-PAM plus 5-fluorouracil (5-FU).
Cancer. 1977 Jun;39(6 Suppl):2883-903. doi: 10.1002/1097-0142(197706)39:6<2883::aid-cncr2820390676>3.0.co;2-9.
Zotero 插件